DJIA 17,656.14 -27.44 -0.16%
NASDAQ 4,964.09 -27.85 -0.56%
S&P 500 2,068.12 -0.64 -0.03%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.52 -0.01 (-1.43%)

Quote as of


company name or ticker

Recent Quotes

STEM $0.52 -1.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.54
Previous Close $0.53
Daily Range $0.52 - $0.54
52-Week Range $0.49 - $2.35
Market Cap $54.9M
P/E Ratio -1.02
Dividend (Yield) $0.00 (0.0%)
Volume 375,360
Average Daily Volume 2,935,540
Current FY EPS -$0.41

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Will StemCells (STEM) Continue to Surge Higher? - Tale of the Tape

Health Care Sector Update for 06/04/2015: RGLS, NVGN, STEM

StemCells (STEM) Worth Watching: Stock Rises 10.7% - Tale of the Tape

Cantor: Time To Buy StemCells

Benzinga's Top Initiations

HC Wainwright: Buy StemCells, It's Worth $1/Share

StemCells (STEM) Q1 2015 Results - Earnings Call Webcast

Dissecting StemCells Latest Capital Raise

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal C

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury

Porat To Google Just One Of The Week's Top Management Changes; Here Are 7 More

See More STEM News...

STEM's Top Competitors

STEM $0.52 (-1.43%)
Current stock: STEM
AMGN $154.77 (0.17%)
Current stock: AMGN
GILD $114.63 (-0.89%)
Current stock: GILD
BIIB $407.15 (0.62%)
Current stock: BIIB